Key Events This Week
6 Apr: Week opens at Rs.923.40
8 Apr: New 52-week and all-time highs hit; stock surges 5.00%
9 Apr: Upper circuit hit; closes at Rs.1008.95 (+4.98%)
10 Apr: Hits new 52-week high at Rs.1022; closes at Rs.994.15 (+1.89%)
6 April 2026: Steady Start Amid Market Stability
Venus Remedies began the week at Rs.923.40, with a relatively quiet session and volume of 3,003 shares. The Sensex closed at 33,229.93, setting a baseline for the week. The stock showed no significant price movement on 7 April, closing marginally lower by 0.01% at Rs.923.35, while the Sensex gained 0.50%, indicating initial consolidation before the week’s rally.
8 April 2026: Breakout to New 52-Week and All-Time Highs
On 8 April, Venus Remedies surged 5.00% to close at Rs.969.50, hitting a new 52-week high. The stock also reached an all-time intraday high of Rs.947 earlier in the session, reflecting strong buying momentum. This move outpaced the Sensex’s 3.88% gain and the Pharmaceuticals & Biotechnology sector’s modest 0.17% rise, underscoring the stock’s relative strength.
Robust financial results underpinned this rally, with the company reporting a 96.37% increase in operating profit for the December 2025 quarter and five consecutive quarters of positive earnings. The stock traded above all key moving averages, signalling sustained bullish momentum. Delivery volumes, however, showed a decline, suggesting some speculative trading interest.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
9 April 2026: Upper Circuit and New Highs Amid Market Weakness
Venus Remedies continued its strong run on 9 April, hitting an upper circuit limit with a 4.98% gain to close at Rs.1008.95, marking a new 52-week and all-time high. The stock opened with a gap-up of 4.07% and traded in a range up to Rs.1017.95, outperforming the Sensex which declined 0.56% that day.
The surge was supported by increased delivery volumes, rising 142.02% compared to the five-day average, indicating genuine accumulation by investors. Technical indicators remained bullish, with the stock trading above all key moving averages and supported by positive MACD and Bollinger Bands signals. Despite the micro-cap status and inherent volatility, the stock demonstrated resilience and strong investor interest.
10 April 2026: New 52-Week High and Sustained Momentum
On the final trading day of the week, Venus Remedies hit a fresh 52-week high of Rs.1022, closing at Rs.994.15 after a 1.89% gain. The stock outperformed the Sensex’s 1.40% rise, maintaining its bullish trend. The session featured a gap-up open of 3.33%, reflecting continued robust buying interest.
Financial metrics remained strong, with a debt-free balance sheet, 116.9% growth in quarterly PAT, and a Return on Capital Employed of 13.99%. The company’s Price to Earnings ratio stood at 17x, with a low PEG ratio of 0.09x, indicating attractive valuation relative to earnings growth. Institutional investors increased their stake by 0.67% in the previous quarter, now holding 3.28% of shares, signalling growing confidence.
Get the full story on Venus Remedies Ltd! Our detailed research dives into fundamentals, sector comparison, technical analysis, and valuations for this micro-cap. Make informed decisions!
- - Full research story
- - Sector comparison done
- - Informed decision support
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-04-06 | Rs.923.40 | - | 33,229.93 | - |
| 2026-04-07 | Rs.923.35 | -0.01% | 33,395.05 | +0.50% |
| 2026-04-08 | Rs.969.50 | +5.00% | 34,690.59 | +3.88% |
| 2026-04-09 | Rs.975.75 | +0.64% | 34,521.99 | -0.49% |
| 2026-04-10 | Rs.994.15 | +1.89% | 35,004.96 | +1.40% |
Key Takeaways
Venus Remedies Ltd’s 7.66% weekly gain notably outperformed the Sensex’s 5.34% rise, driven by a series of new 52-week and all-time highs. The stock’s strong financial performance, including a 96.37% increase in operating profit and 116.9% growth in PAT, underpinned investor confidence. Technical indicators consistently signalled bullish momentum, with the stock trading above all key moving averages and hitting upper circuit limits on multiple days.
Institutional investors increased their stake, reflecting growing confidence in the company’s fundamentals. However, the micro-cap status and occasional declines in delivery volumes suggest some speculative trading and potential volatility. The company’s modest long-term sales growth of 6.29% contrasts with rapid earnings expansion, highlighting operational efficiencies as a key driver of recent gains.
Overall, Venus Remedies demonstrated resilience and strength amid mixed market conditions, supported by robust fundamentals and positive technical signals.
Conclusion
Venus Remedies Ltd’s performance in the week ending 10 April 2026 highlights a compelling growth story marked by strong earnings, technical strength, and increasing institutional interest. The stock’s ability to hit multiple new highs and sustain gains despite broader market fluctuations underscores its relative strength within the Pharmaceuticals & Biotechnology sector. While the micro-cap nature introduces some volatility risk, the company’s solid financial metrics and positive market sentiment position it as a noteworthy stock for investors monitoring growth opportunities in this space.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
